Publications by authors named "Ian P Stolerman"

Claim this Profile
L
Long-term effects of gestational nicotine exposure and food-restriction on gene expression in the striatum of adolescent rats.
Nicholas E Ilott, Tomasz Schneider, Jonathan Mill, Leonard Schalkwyk, Giovana Brolese, Ian P Stolerman

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine.
Davide Quarta, Christopher G Naylor, Jeffrey C Glennon, Ian P Stolerman

Behav Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement.
Britta Hahn, Mohammed Shoaib, Ian P Stolerman

Psychopharmacology (Berl)· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of training dose in drug discrimination: a review.
Ian P Stolerman, Emma Childs, Matthew M Ford, Kathleen A Grant

Behav Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats.
Tomasz Schneider, Nicholas Ilott, Giovana Brolese, Lisiane Bizarro, Philip J E Asherson, Ian P Stolerman

Neuropsychopharmacology· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gestational exposure to nicotine in drinking water: teratogenic effects and methodological issues.
Tomasz Schneider, Lisiane Bizarro, Philip J E Asherson, Ian P Stolerman

Behav Pharmacol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The duration of nicotine-induced attentional enhancement in the five-choice serial reaction time task: lack of long-lasting cognitive improvement.
Ian P Stolerman, Christopher G Naylor, Azam Mesdaghinia, Hannah V Morris

Behav Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.
Davide Quarta, Christopher G Naylor, Jacques Barik, Cathy Fernandes, Susan Wonnacott, Ian P Stolerman

Psychopharmacology (Berl)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognising nicotine: the neurobiological basis of nicotine discrimination.
Janice W Smith, Ian P Stolerman

Handb Exp Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The language barrier and institutional provincialism in science.
Ian P Stolerman, Kerstin Stenius

Drug Alcohol Depend· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats.
Svetlana Semenova, Ian P Stolerman, Athina Markou

Pharmacol Biochem Behav· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.
Davide Quarta, Christopher G Naylor, Hannah V Morris, Swital Patel, Rachel F Genn, Ian P Stolerman

Neuropharmacology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination.
Davide Quarta, Christopher G Naylor, Ian P Stolerman

Psychopharmacology (Berl)· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines on nicotine dose selection for in vivo research.
Shannon G Matta, David J Balfour, Neal L Benowitz, R Thomas Boyd, Jerry J Buccafusco, Ian P Stolerman

Psychopharmacology (Berl)· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine psychopharmacology research: advancing science, public health, and global policy.
Jack E Henningfield, Ian P Stolerman, Klaus A Miczek

Psychopharmacology (Berl)· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists.
Britta Hahn, Ian P Stolerman

Psychopharmacology (Berl)· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats.
Britta Hahn, Mohammed Shoaib, Ian P Stolerman

Psychopharmacology (Berl)· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attentional effects of nicotinic agonists in rats.
Britta Hahn, Christopher G V Sharples, Susan Wonnacott, Mohammed Shoaib, Ian P Stolerman

Neuropharmacology· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional magnetic resonance neuroimaging of drug dependence: naloxone-precipitated morphine withdrawal.
Andrew S Lowe, Steve C R Williams, Mark R Symms, Ian P Stolerman, Mohammed Shoaib

Neuroimage· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis